Risankizumab vs Vancomycin

## Risankizumab vs Vancomycin: Overview

This comparison examines the pharmacological differences between **Risankizumab** and **Vancomycin**.

## Mechanism of Action

**Vancomycin**: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.

## Pharmacokinetics

**Half-life**: Risankizumab — N/A; Vancomycin — 4-6 hours.

## Chemical Properties

**Molecular Formula**: Risankizumab — N/A; Vancomycin — C66H75Cl2N9O24.

**Molecular Weight**: Risankizumab — N/A; Vancomycin — 1449.2500 g/mol.

**Type**: Risankizumab — Antibody; Vancomycin — Small molecule.